This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Celik Halat ve Tel Sanayi fails in bid to legally halt US trade probes on Turkish PC strand

By Kat Lucero ( December 7, 2020, 21:28 GMT | Insight) -- Turkish steel firm Celik Halat ve Tel Sanayi’s claim that it would suffer “irreparable harm” with the imposition of US initial import duties on steel wires from Turkey has been rejected by the US Court of International Trade, which ruled that the trade remedy investigations are still ongoing and, therefore, not ripe for legal review. The decisions come as Commerce and the International Trade Commission are wrapping the final phase of investigations into the imports from 15 countries, including Turkey.Turkish steel firm Celik Halat ve Tel Sanayi’s claim that it would suffer “irreparable harm” with the imposition of US initial import duties on steel wires from Turkey has been rejected by the US Court of International Trade, which ruled that the trade remedy investigations are still ongoing and, therefore, not ripe for legal review....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections